Last Funding Date: 2021-11-29
Investors Number: 14.0
Industry: Early Drug Development
Last Funding Type: Series C
Headquarters: Boston, Massachusetts, United States
Total Funding: 210000000.0
Funding Status: Late Stage Venture
Employee Number: 11-50
Technology: Anti-infective Drugs
Estimated Revenue: $1M to $10M
Founded Date: 2017-01-01